Results can vary, but many users start to see significant changes within two to three months of consistent use, in ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

WHILE enjoying the last burst of summer sunshine, it’s natural that you might start to feel a bit glum. Believe it or not, ...

Zmyra's formula includes several active components. Caffeine anhydrous gives users an energy boost and may help burn fat.

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting ...

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and ...

GI and liver disease in pregnancy should be managed with preconception and contraceptive counseling, coordination of birth, ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting ...

2024年9月27日14:00-15:30，生物谷联手Bio-Techne倾力打造空中讲坛“科研面对面！探索高分文章及课题思路解析”，邀请到优秀文章的作者倾囊相授，分享发表高分文字的科研秘籍。此次讲坛不仅是一次学术上的碰撞与交流，更为广大科研工作者提 ...

Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...